Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells

Area of Science:

• Stem cell biology
• Regenerative medicine
• Vascular biology

Background:

• Endothelial progenitor cells (EPCs) are crucial for vascular repair.
• Generating functional EPCs from embryonic stem cells (ESCs) is a key goal in regenerative medicine.
• Non-human primate models offer translational relevance for human therapies.

Purpose of the Study:

• To establish a protocol for generating CD34+ EPCs from baboon ESCs.
• To characterize the properties of these derived EPCs.
• To evaluate the therapeutic potential of baboon EPCs in vascular repair.

Main Methods:

• Sequential differentiation of baboon ESCs through embryoid bodies and monolayer cultures.
• Characterization of EPCs using flow cytometry for markers like CD34, CXCR4, UEA-1, CD31, and CD117.
• Assessment of EPC functional properties, including lumen formation and Dil-LDL uptake.
• Ex vivo evaluation of CD34+ EPCs for vascular repair in a denuded arterial segment model.

Main Results:

• A step-wise protocol successfully generated CD34+ EPCs from baboon ESCs.
• Derived EPCs expressed specific endothelial markers (CD34, CXCR4, UEA-1) and exhibited functional characteristics.
• Angioblasts specified in ECGS medium showed a higher percentage of CD34+/CXCR4+ cells compared to EGM-2 medium.
• Fluorescently labeled CD34+ EPCs integrated into a denuded arterial surface ex vivo and expressed mature endothelial markers (CD31, CD146).

Conclusions:

• Baboon ESC-derived CD34+ EPCs can be generated using a defined protocol.
• These EPCs possess functional characteristics and therapeutic potential for vascular repair.
• The study provides a foundation for using primate ESC-derived EPCs in regenerative strategies for vascular diseases.